Leukemic cells from two patients with Philadelphia-negative chronic myeloid leukemia (CML) were investigated: I) Cytogenetics showed a normal 46,XY karyotype in both cases, 2) molecular studies revealed rearrangement of the M-BCR region and formation of BCR-ABL fusion mRNA with b2a2 (patient I) or b3a2 (patient 2) configuration, and 3) fluorescence in situ hybridization (FISH) demonstrated relocation of the 5' BCR sequences from one chromosome 22 t o one chromosome 9. The ABL probe hybridized t o both chromosomes 9 at band q34, while two other probes which map centromeric and telomeric of BCR on 22q I I hybridized solely with chromosome 22. For the first time, a BCR-ABL rearrangement is shown t o take place on 9q34 instead of in the usual location on 22q I I. A rearrangement in the latter site is found in all Ph-positive CML and in almost all investigated CML with variant Ph or Ph-negative, BCR-positive cases. The few aberrant chromosomal localizations of BCR-ABL recombinant genes found previously were apparently the result of complex and successive changes. Furthermore in patient 2, both chromosomes 9 showed positive FISH signals with both ABL and BCR probes. Restriction fragment length polymorphism (RFLP) analysis indicated that mitotic recombination had occurred on the long arm of chromosome 9 and that the rearranged chromosome 9 was of paternal origin. The leukemic cells of this patient showed a duplication of the BCR-ABL gene, analogous t o duplication of the Ph chromosome in classic CML. In addition they had lost the maternal alleles of the 9q34 chromosomal region. The lymphocytes of patient 2 carried the maternal chromosome 9 alleles and were Ph-negative as evidenced by RFLP and FISH analyses, respectively. Genes Chrorn Cancer 8:237-245 (1993).
INTRODUCTION
T h e t(9;22)(q34;ql l ) , i.e., the Philadelphia (Ph) translocation, is the cytogenetic hallmark of chronic myeloid leukemia (CML) in which it is observed in more than 90% of the cases. Molecularly, the translocation results in the formation of a chimeric BCR-ABL gene that encodes a chimeric BCR-ABI, protein. T h e chromosome 22 breakpoint is generally, but not exclusively, located in a 5 kb BgIII fragment of the BCR gene, the so-called major breakpoint cluster region (M-BCR). Depending upon the position of the breakpoint within M-BCR, two exons (b2 and b3) can be spliced to exon a2 of the ABL gene to form the chimeric BCR-ABL niRNA .
Cytogenetic variants of the Ph translocation can be studied by Southern blotting to demonstrate a rearrangement in the M-BCR or by RNA-PCR to show the specific junction type, b2a2 or b3a2, in the mRNA of the recombinant gene. We and others have demonstrated that the cytogenetic variants of the Ph (simple, complex, masked Ph) resulted in the same molecular BCR-ABL recombination as in the standard Ph (Hagemeijer et al., 1984 (Hagemeijer et al., , 1985 Bartram et al., 1985; Morris et al., 1988; Dube et al., 1989) .
A small number of patients with C M L do not show any evidence of a Ph chromosome. T h e majority of these have a normal karyotype, some have abnormalities involving chromosome 9 at band q34 or other changes, but invariably the chromosome 22 appears normal. When investigated by molecular means, some cases show evidence of an M-BCR rearrangement or a BCR-ABL mRNA. T h e remaining cases are Ph-negative cytogenetically and molecularly and show slightly different pathological features and shorter survival (Martiat et al., 1991; Van der Plas et al., 1991) .
Metaphase cells from Ph-negative but molecularly M-BCR-positive CML patients have been studied using in situ hybridization (ISH) with probes specific for the ABL and BCR genes. This technique has demonstrated co-localization of the probes and by inference the genes map to the same chromosomal band. In at least six cases, translocation of ABL to chromosome 22 was demonstrated (Ganesan et al., 1986; Morris et al., 1986; Dreazen et al., 1987; Inazawa et al., 1989) . We report 2 CML patients with a normal leukemic karyotype who showed the recombined BCR-ABL gene located in chromosome 9 at band q34. In one of the cases, there was evidence for somatic recombination giving rise to a population with two chromosomes 9 carrying the BCR-ABL gene.
CASE REPORTS

Patient I
J.W. was admitted with a recent history of weight loss (5 kg) and appearance of tumors on the head. There were no complaints of dyspnoea, dizziness, or headache. Physical examination showed a pale 22-year-old male with a congenital malformation of the thorax and right hand, with three tumors on his head with a size of 2 x 3 crn each, and enlarged lymph nodes in the submandibular and axillar region (3 X 3 cm). There was splenomegaly 8 cm below the left costal margin but no hepatomegaly. Fundoscopy showed dilated tortuous blood vessels and numerous hemorrhages in the retina. Laboratory investigations revealed a hemoglobin of 4.9 mmol/l, platelets 263 x 109/1, and leucocytes of 405 X 109/1 with 13% basophils, 3% eosinophils, 7% band forms, 32% neutrophils, 12% promyelocytes, 19% myelocytes, and 14% metamyelocytes. Serum LDH was 900 U/I. Leucocyte alkaline phosphatase was absent. T h e bone marrow was hypercellular with a myeloid/erythroid ratio of 8: 1, a prominent increase in basophils, and a normal karyotype. Treatment with leukapheresis and hydroxyurea produced a good response initially. Two months later the patient developed thrombocytosis and became unresponsive to hydroxyurea. Bone marrow examination showed a lymphoblastic crisis and an abnormal karyotype, 47,XY,+mar (JSCN 1991) . T h e patient was treated with multiple combination chemotherapy regimens without success. H e died 10 months after diagnosis.
Patient 2
W.K. was referred to the hospital because of hyperleucocytosis found at a routine laboratory analysis. He had a slight prostatism and a recent loss of weight (5 kg). Physical examination showed a healthy, 49-year-old male with splenoniegaly 6 crn below the left costal margin. Laboratory investigations revealed a hemoglobin of 6.8 mmol/l, platelets 156 x 109/1, and leucocytes 322
Microscopic examination of a peripheral blood smear showed myeloid cells at all stages of development with some hypersegmented forms. There were 2% basophils, 3% eosinophils, 15% bands, 48% neutrophils, 2% blasts, 7% promyelocytes, 17% myelocytes, and 6% metamyelocytes. Serum L D H was 1,017 U/I. Leucocyte alkaline phosphatase activity was absent. T h e bone marrow was hypercellular with a myeloid/erythroid ratio of 40: 1, no increase in bone marrow blasts, and a normal karyotype.
Treatment with hydroxyurea resulted in a reduction in spleen size and peripheral leucocyte counts. T h e patient has been followed for about 9 months. His disease is still in chronic phase but is very difficult to stabilize with highly variable WBC. He has an HLA-identical MLC-negative brother, and an allogeneic bone marrow transplantation is planned.
MATERIALS A N D METHODS
Patient Material and Cytogenetics
Bone marrow and blood cells from both patients were obtained at diagnosis and at various times during the course of the disease. Cytogenetic analysis was carried out according to our standard procedure (Hagemeijer et al., 1979) . Diagnostic rnaterial of both cases was kept frozen in 10% DMSO in liquid N, and thawed for molecular studies. New cultures of thawed diagnostic bone marrow from patient 1 were used for FISH analyses. T h e same cultures were used for cytogenetic and in .siru hybridization studies of patient 2.
Southern Blotting
DNA was extracted from bone marrow cells of both patients and from a normal thymus. T o detect a rearrangement of the M-BCR, Southern blots containing DNA, digested with BcoRI, BarnHI, HindIII, and BgIII were hybridized to three probes: 1) 5' BCR: a 2 kb BglII-Hind111 fragment, 2) 3' BCR, a 1.2 kb HindIII-BgllI fragment, and 3) the universal BCR probe (Oncogene Sciences, Mineola, NY).
T o perform RFLP analysis of chromosome 9, DNA from bone marrow and peripheral blood from patient 2 was digested with BstXI, TaqI, and HindIII, blotted and hybridized with probes 26p (locus D9S5, obtained from ATCC, Rockville, MD), hAKlB3.25 (AK1, N.T. Bech-Hansen), ASSgl (ASS, ATCC), MCT136 (D9S10, Y. Nakamura), and EFD126.3 (D9S7, Y. Nakamura). DNA of the patient's mother, obtained from peripheral blood, was similarly digested with TaqI and HindIII, blotted, and hybridized with EFD 126.3, hAKlB3.25, and ASSGl, sequentially.
T h e parental origin of each allele was deduced from the haplotypes.
RNA-PCR Analysis
Total RNA was extracted by the guanidine-thiocyanate method (Chomczynski and Sacchi, 1987) .
lising antisense ABL primer a3 and reverse transcriptase (Superscript, Gibco BRL, Grand Island, NY), cDNA was obtained and subsequently amplified using 2.5 units Taq polymerase (Boehringer Mannheim, Indianapolis, IN) in the presence of sense primers of BCR gene b2 and 1st exon e l .
T h e technique, primers, and detection oligonucleotides were as described by Hermans et al. (1988) .
As internal positive control in the PCR, an ABL fragment was amplified (Van der Plas et al., 1989) . Twenty-four cycles of amplification were performed. T h e samples were electrophoresed and transferred to nylon filters (Zetaprobe), which were hybridized to 32P end-labeled oligonucleotides, spanning the el-az and bZ-a2 and b3-a2 junctions. After hybridization the blots were washed and exposed to Fuji XR films (Tokyo, Japan).
Fluorescence In Situ Hybridization (FISH)
T h e probes were labeled by standard nick translation using either biotin-16-dUTP or digoxigenin-1 1-dUTP (both from Boehringer-Mannheim). In double color FISH a mixture of two differently labeled probes was used. After heat denaturation, 25 to 50 ng of probe was preannealed with 10 p,g of Cot-1 DNA for 1-3 hr at 37°C. T h e hybridization mixture contained the probes and Cot-1 DNA in 50% formamide, 10% dextran-sulphate in 2 x SSCP. All details concerning pretreatment of slides, hybridization, washing, and immunochemical detection were as reported (Arnoldus et al., 1990) . T h e probes used were 1) Cos-ABL-18, a 40 kb fragment containing the 3' coding region of the human ABL gene, 2 ) Cos-BCR-16 containing a 32 kb fragment representing most of the first exon and part of the first intron of BCR, 3) Cos X 3.1, a cosmid containing sequences of the constant part of the ZGL gene that maps on chromosome 22 centromeric of BCR, 4) 40D2, a cosmid containing sequences that map on 22qll a few megabases telomeric of the BCR gene, and 5) pHUR98, a satellite 111 DNA probe, was used at low concentration (5 ng/lO PI). This probe recognizes specifically the polymorphic paracentromeric region of chromosome 9. It was used to facilitate the identification of chromosomes 9 in the metaphase cells. Whenever possible, 20 to 35 metaphases were scored with each probe. Chromosomes were identified by DAPI banding or by combined hybridization with centromere specific probes.
RESULTS
Cytogenetics
Patient I showed, at diagnosis, a normal karyotype (46,XY) in 44 bone marrow metaphase cells. In particular, using various banding techniques, no structural aberrations were seen on chromosomes 9 and 22 (Fig. 1A) . Three months later, during blast crisis, the 32 karyotyped metaphases showed 47 chromosomes, with an extra marker that looked like a slightly elongated chromosome 21. T h e remaining 46 chromosomes appeared structurally normal. After blast crisis therapy, the percentage of cells with 47 chromosomes regressed but never disappeared. Patient 2 bone marrow cells showed a normal 46,XY karyotype in all 32 metaphase cells analyzed at diagnosis (Fig. 1B) .
Molecular Investigations of BCR and ABL
T h e results of Southern blotting analysis are given in Table 1 . T h e presence of aberrant restriction fragments in the various digests indicated rearrangement of the M-BCR in both patients.
T h e results of PCR amplification of cDNA followed by hybridization to breakpoint specific oligonucleotides are shown in Figure 2 . A 319 base pair (bp) fragment corresponding to b2-aZ joining in the BCR-ABL mRNA was found in patient 1. A 394 bp fragment corresponding to b3-a2 joining was found in patient 2 . As expected, neither b2-a2 nor b3-a2 joining was detected in the leucocytes of a healthy control.
Fluorescence In Situ Hybridization (FISH)
Most of the FISH analyses were performed with probes labeled with biotin and detected with avidin FITC. Using fluorescene microscopy, the yellow-green hybridization signal was easily detected on the red background of propidium iodide stained chromosomal DNA.
T h e results are illustrated in Figures 3 and 4 and summarized in Table 2 . In a normal control, the ABL probe hybridized to both chromosomes 9 at band q34 and the BCR probes to both chromosomes 22. In CML controls with a standard t(9;22), Cos-ABL-18 hybridized to the normal 9 at band q34, and the 22q-and Cos-BCR-16 hybridized to 22 and 22q-(data not shown). In both patients the ABL probe hybridized to both chromosomes 9 at band q34, as it did in normal individuals. T h e BCR probe in patient 1 showed two signals, one on chromosome 9 and one on chromosome 22. In patient 2, three BCR signals were seen in most metaphases, on one chromosome 22 and on both chromosome bands 9q34 (Fig. 4) . T h e aberrant localization of BCR on chromosome 9 was confirmed independently in both patients using cohybridization of the BCR probe and pHUR98, a probe specific for the paracentromeric region of chromosome 9. In both patients, the two remaining probes that map centromeric and telomeric of BCR on chromosome 22 hybridized exclusively to both chromosomes 22. These results are best interpreted by suggesting an insertion of the 5' part of the BCR gene within or at the 5' side of the ABL gene on one chromosome 9. In patient 2 , both chromosomes 9 showed BCR as well as ABL signals in 17 of the 20 metaphases analyzed. This could be due to duplication of the rearranged chromosome 9 the findings on metaphase chromosomes. T w o months after the start of therapy, when the peripheral WBC had dropped to 12 x 109/1 and the differential count showed 18% lymphocytes, a PHA stimulated blood culture was done and metaphase chromosomes were hybridized to the probes. T e n metaphase cells were analyzed for each probe, which showed a hybridization pattern corresponding to normal, non-rearranged cells, i.e., ABL on both chromosomes 9, BCR, X 3.1, and 40D2 on both chromosomes 22 (Table 2 ). This indicated absence of BCR-ABL rearrangement in T-lymphocytes, as expected. A control hybridization was done on bone marrow cells, 6 months after the beginning of therapy. Three signals for BCR were seen in 15 out of 15 metaphases and in 78% of the nuclei, indicating the persistence of a double BCR-ABL recombination in a substantial percentage of marrow cells.
RFLP Analysis
To further investigate the mechanism by which both chromosomes 9 are involved in Ph rearrangement in patient 2, RFLP analysis of polymorphic markers of 9q was performed on bone marrow and blood from the patient as well as on blood from his mother. At the time of study, blood from the patient contained a mixture of leukemic cells and normal lymphocytes. Material from the father was not available. T h e results showed a partial loss of some maternal chromosome 9 alleles ( Fig. 5 ; Table  3 ). T h e proximal marker 26p retained heterozygosity, while the more distal markers hAKlB3.25, ASSgl, MCT136, and EFD126.3 showed homozygosity (or hemizygosity) in the bone marrow cells and the majority of blood cells (Fig. 5 , lanes A and B, respectively). In particular, the maternal alleles for ASSGl and EFD126.3 markers were absent from the patient's bone marrow. This can be explained by assuming that in the leukemic cells a mitotic recombination had occurred between 26p and AK1, resulting in homozygosity of all paternal alleles on chromosome 9, at band q34, including duplication of the BCR-ABL gene. These results also suggest that the paternal chromosome 9 was involved in the formation of the BCR-ABL hybrid gene in this patient.
DISCUSSION
Analyses of leukemic cells from 2 C M L patients showed a normal karyotype but molecular changes corresponding to a Ph translocation. FISH with cosmids specific for 3' ABL and 5' BCR showed aberrant localization of 5' BCR sequences on chromosome band 9q34. As evidenced by RNA-PCR, a classic RCR-ABL mRNA was encoded in both cases. This is to the best of our knowledge the first time that relocation of 5' BCR sequences to chromosome 9 is documented. A number of other cases of CML with an apparently normal karyotype have been investigated. In at least six cases, translocation or insertion of ABL sequences on one chromosome 22 within the BCR gene was demonstrated (Morris et al. 1986 (Morris et al. , 1990 Ganesan et al., 1986; Dreazan et al., 1987; Inazawa et al., 1989) , whereas in at least three cases RCR and ABL sequences were shown to be located on different chromosome arms like l p or 2Op (Van der Plas et al., 1989; Morris et al., 1991) . T h e latter situation is more often observed when changes of 9q34 are visible cytogenetically (Bartram et al., 1985; Kurzrock et al., 1986; Van der Plas et al., 1989) . In the latter cases there are often residual 3' BCR sequences on the der(9) that suggest occurrence of at least two successive translocations, i.e., t(9;22) followed by translocation between the der( 22) and a third chromosome, displacing the BCR-ABL chimeric gene and restoring an apparent integrity of chromosome 22 at the cytogenetic level.
Our observations in the two cases reported here suggest that BCR sequences were inserted at the 5' side of the ABL gene. But investigation at the genomic level using pulsed-field gel electrophoresis (PFGE) or cloning and sequencing have not been performed and we cannot exclude the possibility of two successive translocations, first a classic t(9;22) followed by a second translocation between both derivatives, i.e., 9 q + and 22q-, masking the first chromosomal exchange.
FISH with specific cosmid probes is a highly efficient tool for the study of such cases: they provide clear hybridization signals on both chromatids of the target chromosomes which are clearly distinguishable from background hybridization signals. Furthermore, all mitotic cells are informative. Using two-color FISH it is possible to see the confluence of labeled sequence on the same chromosome band, while the homologous chromosome carries only one of the genes. This is particularly important in cases where rearranged chromosomes are not morphologically distinguishable from their normal homologs.
T h e cases studied here should make cytogeneticists aware of the fact that use of FISH with only the ABL probe to analyze Ph-negative C M L can be misleading: FISH of ABL probe in our two cases conformed with a normal karyotype. Hybridization of 5' BCR sequences indicated abnormality, as did the molecular studies.
Duplication of the Ph is a frequent evolutionary event in CML. In patient 2 , we showed that duplication occurred by somatic crossing over of the long arm of chromosome 9 and loss of maternal alleles. Reeve et al. (1988) described a similar phenomenon, i.e., loss of germline BCR sequences and duplication of rearranged BCR sequences as well as acquired homozygosity of ZGL sequences. Other genes on chromosome 22 were not investigated. In our patient 2, duplication of the BCR-ABL allele allowed the use of RFLP analysis. Our study indicated that the rearranged chromosome 9 was of paternal origin, which is in line with the results reported recently by Haas et al. (1992) . These authors analyzed the cytogenetically polymorphic regions on 9 q l l and 2 2 p l l in 15 C M L patients with t(9;22) and their parents. T h e 9 q + was shown to be of paternal origin and the 22q-of maternal origin. In our patient 2 , the proximal part of the duplicated chromosome 9 (marker 26p, Fig.  5 ) retained heterozygosity and hence was of maternal origin.
T h e difference in band intensity for MCT136 and EFD126.3 in the peripheral blood sample (Fig. 5, lane B) reflects the abnormal ratio between myeloid cells carrying the duplication and the number of lymphocytes, which have been shown by FISH ( Table 2 ) not to carry the BCR-ABL hybrid gene and thus to contain both maternal and paternal alleles.
